UBS ASSET MANAGEMENT AMERICAS LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$202,704,000
-29.5%
53,343
-5.5%
0.00%
Q4 2019$287,392,000
-5.0%
56,462
-5.7%
0.00%
Q3 2019$302,668,000
+4.3%
59,875
+27.4%
0.00%
Q2 2019$290,058,000
+63.2%
47,011
+22.7%
0.00%
Q1 2019$177,745,000
+10.5%
38,3070.0%0.00%
Q4 2018$160,889,000
-33.0%
38,3070.0%0.00%
Q3 2018$240,185,000
-22.0%
38,3070.0%0.00%
Q2 2018$307,987,000
-13.7%
38,307
-20.0%
0.00%
Q1 2018$356,999,000
+51.7%
47,855
+21.0%
0.00%
Q4 2017$235,317,000
-19.2%
39,5490.0%0.00%
Q3 2017$291,080,000
+10.7%
39,549
+2.1%
0.00%
Q2 2017$262,936,000
-28.1%
38,7240.0%0.00%
Q1 2017$365,554,000
+154142.2%
38,724
+41.2%
0.00%
Q4 2016$237,000
-1.2%
27,424
-27.6%
0.00%
Q3 2016$240,000
+66.7%
37,862
+11.0%
0.00%
Q2 2016$144,000
-3.4%
34,1000.0%0.00%
Q1 2016$149,000
-28.7%
34,1000.0%0.00%
Q4 2015$209,000
-0.9%
34,100
-7.6%
0.00%
Q3 2015$211,000
-16.9%
36,900
+8.2%
0.00%
Q2 2015$254,00034,1000.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
Phocas Financial Corp. 1,033,328$6,376,0000.68%
ARDSLEY ADVISORY PARTNERS LP 650,000$4,011,0000.63%
Worth Venture Partners, LLC 138,357$853,0000.47%
RICE HALL JAMES & ASSOCIATES, LLC 2,242,503$13,836,0000.46%
HIGHLAND CAPITAL MANAGEMENT LP 716,880$4,423,0000.26%
FARALLON CAPITAL MANAGEMENT LLC 5,543,386$34,203,0000.22%
Point72 Asset Management, L.P. 5,858,749$36,148,0000.19%
PINNACLE ASSOCIATES LTD 1,298,723$8,013,0000.19%
Fosun International Ltd 472,580$2,750,0000.18%
J. Goldman & Co LP 400,000$2,468,0000.17%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders